These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11504310)

  • 1. Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation.
    Horsman MR; Murata R; Overgaard J
    Acta Oncol; 2001; 40(4):497-503. PubMed ID: 11504310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of vascular targeting agents with thermal or radiation therapy.
    Horsman MR; Murata R
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1518-23. PubMed ID: 12459380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL; Horsman MR
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.
    Murata R; Overgaard J; Horsman MR
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1018-24. PubMed ID: 11704326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo interaction between flavone acetic acid and hyperthermia.
    Horsman MR; Sampson LE; Chaplin DJ; Overgaard J
    Int J Hyperthermia; 1996; 12(6):779-89. PubMed ID: 8950158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combining flavone acetic acid and hyperthermia on the growth of a C3H mammary carcinoma in vivo.
    Horsman MR; Chaplin DJ; Overgaard J
    Int J Radiat Biol; 1991; 60(1-2):385-8. PubMed ID: 1677999
    [No Abstract]   [Full Text] [Related]  

  • 8. Flavone acetic acid increases the antitumor effect of hyperthermia in mice.
    Sakaguchi Y; Maehara Y; Baba H; Kusumoto T; Sugimachi K; Newman RA
    Cancer Res; 1992 Jun; 52(12):3306-9. PubMed ID: 1596889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Overgaard J; Horsman MR
    Int J Hyperthermia; 2001; 17(6):508-19. PubMed ID: 11719967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J; Radacic MM; Grau C
    Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation.
    Horsman MR
    Int J Hyperthermia; 2015; 31(5):453-9. PubMed ID: 25915829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment.
    Overgaard J; Radacic M; Skaric D; Skaric V; Horsman MR; Lindegaard JC; Jercic J
    Int J Hyperthermia; 1993; 9(6):821-30. PubMed ID: 8106823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a combination of mild-temperature hyperthermia and nicotinamide on the radiation response of experimental tumors.
    Ogawa A; Griffin RJ; Song CW
    Radiat Res; 2000 Mar; 153(3):327-31. PubMed ID: 10669555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hyperthermia on reoxygenation during the fractionated radiotherapy of two murine tumors, FSa-II and MCa.
    Nishimura Y; Urano M
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):141-8. PubMed ID: 8175421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of mammary tumors of C3H/He mice to hyperthermia and bleomycin in vivo.
    Ma F; Hiraoka M; Jo S; Akuta K; Nishimura Y; Takahashi M; Abe M
    Radiat Med; 1985; 3(4):230-3. PubMed ID: 2425397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of step-down heating on the interaction between heat and radiation in a C3H mammary carcinoma in vivo.
    Lindegaard JC; Grau C; Overgaard J
    Int J Radiat Biol; 1991 Oct; 60(4):707-21. PubMed ID: 1680149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo.
    Mao HS; Grau C; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(1):115-22. PubMed ID: 1727107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological changes in transplanted mouse mammary carcinoma following hyperthermia with or without radiation.
    Jo S; Hiraoka M; Akuta K; Nishimura Y; Furuta M; Takahashi M; Abe M
    Jpn J Cancer Res; 1986 Nov; 77(11):1095-101. PubMed ID: 3098719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.